Chronic obstructive pulmonary disease and its comorbidities

被引:0
作者
Panetta, N. L. [1 ]
Krachman, S. [1 ]
Chatila, W. M. [1 ]
机构
[1] Temple Univ, Sch Med, Div Pulm & Crit Care, Philadelphia, PA 19140 USA
关键词
Pulmonary disease; chronic obstructive; Epidemiology; Lung diseases; GASTROESOPHAGEAL-REFLUX DISEASE; BONE-MINERAL DENSITY; FORCED EXPIRATORY VOLUME; LUNG-CANCER INCIDENCE; FAT-FREE MASS; UNITED-STATES; COPD PATIENTS; CORTICOSTEROID USE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Comorbidities of chronic obstructive pulmonary disease (COPD) include pneumonia, pulmonary embolism, lung cancer, musculoskeletal dysfunction, osteoporosis, gastroesophageal reflux disease, cardiac disease, diabetes, hyperlipidemia, anemia, and sleep dysfunction, amongst others. These medical conditions are commonly reported in COPD patients; however, the true prevalence of these conditions based on epidemiological studies is variable. Tobacco exposure is a common risk factor between COPD and many of its comorbidities but there is recent evidence that suggests that the harmful effects of these conditions on COPD is independent of their association with smoking. There has recently been an increasing focus on the impact that these health problems may have on the morbidity and mortality associated with COPD as these are now being recognized as part of the overall burden of the disease. It remains to be seen whether or not effective treatment of COPD reduces the risk of developing one of the comorbidities associated with it as well as if interventions that address specific comorbidities, such as improving anemia or preventing, will alter the natural course of COPD. Further investigation is required to gain a better understanding of the interrelationship between COPD and its comorbidities.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 105 条
[1]  
Altose MD, 2000, NEW ENGL J MED, V343, P1902
[2]   PREVALENCE OF BENIGN ESOPHAGEAL DISEASE IN THE DANISH POPULATION WITH SPECIAL REFERENCE TO PULMONARY-DISEASE [J].
ANDERSEN, LI ;
JENSEN, G .
JOURNAL OF INTERNAL MEDICINE, 1989, 225 (06) :393-401
[3]   Hospitalizations and mortality in the Lung Health Study [J].
Anthonisen, NR ;
Connett, JE ;
Enright, PL ;
Manfreda, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) :333-339
[4]   Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease [J].
Baker, EH ;
Janaway, CH ;
Philips, BJ ;
Brennan, AL ;
Baines, DL ;
Wood, DM ;
Jones, PW .
THORAX, 2006, 61 (04) :284-289
[5]  
Barr R Graham, 2005, Am J Med, V118, P1415
[6]   Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease [J].
Bolton, CE ;
Ionescu, AA ;
Shiels, KM ;
Pettit, RJ ;
Edwards, PH ;
Stone, MD ;
Nixon, LS ;
Evans, WD ;
Griffiths, TL ;
Shale, DJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (12) :1286-1293
[7]   Raised CRP levels mark metabolic and functional impairment in advanced COPD [J].
Broekhuizen, R ;
Wouters, EFM ;
Creutzberg, EC ;
Schols, AMWJ .
THORAX, 2006, 61 (01) :17-22
[8]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[9]  
CALVERLEY PMA, 1982, AM REV RESPIR DIS, V126, P206
[10]   Increased gastro-oesophageal reflux disease in patients with severe COPD [J].
Casanova, C ;
Baudet, JS ;
Velasco, MD ;
Martin, JM ;
Aguirre-Jaime, A ;
de Torres, JP ;
Celli, BR .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :841-845